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cently reported that poor sleep with objective short sleep dura-
tion is a risk factor for hypertension.6 Moreover, poor sleep 
is an independent risk factor for the development of chronic 
insomnia,7 which is associated with significant medical mor-
bidity6,8-10 and mortality.11 Together, these findings suggest that 
poor sleep is a very prevalent condition whose medical effect 
has been underestimated.
Very little is known about the incidence and persistence of 
insomnia symptoms or poor sleep, with 2 studies suggesting 
rates of approximately 30% and 46%, respectively.12,13 Even 
less is known about the risk factors involved in the natural his-
tory of poor sleep in the general population. Furthermore, no 
study to date has explored the role of polysomnographic (PSG) 
variables, such as sleep apnea or sleep duration, in the natural 
history of poor sleep. The 3 objectives of this study were to ex-
amine the risk factors involved in the incidence of poor sleep, 
the persistence of poor sleep, and the evolution of poor sleep 
into chronic insomnia in a large general random sample (the 
Penn State Cohort Study) using both subjective and objective 
(i.e., PSG) data and a longitudinal design.
METHODS
Population
The data presented here were collected as part of a population-
based study of sleep disorders, which used a 2-phase protocol 
to recruit participants from various age groups.2,14,15 In the first 
phase of the study, a sample of adult men and women (age 20 
yr or older) was randomly selected from local telephone house-
INTRODUCTION
The prevalence of insomnia varies widely among epide-
miologic studies ranging from 8-40%. A possible explanation 
for this wide variability is the different criteria used to define 
insomnia. For example, approximately 8-10% of the general 
population suffers from chronic insomnia,1-3 whereas another 
20-30% of the population has insomnia symptoms, i.e., difficul-
ties initiating sleep, difficulties maintaining sleep, early morn-
ing awakening, and/or nonrestorative sleep, at any given time.1-3 
When current Diagnostic and Statistical Manual of Mental Dis-
orders, 4th Edition (DSM-IV) criteria are used, the prevalence 
of insomnia is approximately 20%,4,5 a figure that decreases to 
9% when further criteria is used to define insomnia as severe.4
In our most recent studies, we have used the term poor sleep 
to refer to the presence in an individual of 1 or more insomnia 
symptoms.6-12 This term is very similar to those used in other 
studies, such as insomnia symptoms, symptoms of insomnia, 
or sleep difficulties.2,3,12,13 Despite the high prevalence of poor 
sleep or insomnia symptoms in the general population,2,3 its 
effect on physical and mental health is not clear. We have re-
CLINICAL AND PSG PREDICTORS OF THE NATURAL HISTORY OF POOR SLEEP
http://dx.doi.org/10.5665/sleep.1832
Clinical and Polysomnographic Predictors of the Natural History of Poor Sleep 
in the General Population
Julio Fernandez-Mendoza, PhD1; Alexandros N. Vgontzas, MD1; Edward O. Bixler, PhD1; Ravi Singareddy, MD1; Michele L. Shaffer, PhD2; 
Susan L. Calhoun, PhD1; Maria Karataraki, PsyD1; Antonio Vela-Bueno, MD3; Duanping Liao, MD, PhD2
1Sleep Research and Treatment Center, Department of Psychiatry, and 2Department of Public Health Sciences, Pennsylvania State University College of 
Medicine, Hershey, PA; 3Department of Psychiatry, School of Medicine, Autonoma University, Madrid, Spain
Submitted for publication October, 2011
Submitted in final revised form November, 2011
Accepted for publication December, 2011
Address correspondence to: Alexandros N. Vgontzas, MD, Penn State 
University College of Medicine, Department of Psychiatry H073, 500 Uni-
versity Drive, Hershey, PA 17033; Tel: (717) 531-7278; Fax: (717) 531-
6491; E-mail: avgontzas@psu.edu.
Study Objectives: Approximately 8-10% of the general population suffers from chronic insomnia, whereas another 20-30% of the population has 
insomnia symptoms at any given time (i.e., poor sleep). However, few longitudinal studies have examined risk factors of the natural history of poor 
sleep, and none have examined the role of polysomnographic (PSG) variables.
Design: Representative longitudinal study.
Setting: Sleep laboratory.
Participants: From a random, general population sample of 1,741 individuals of the adult Penn State Cohort, 1,395 were followed up after 7.5 yr.
Measurements: Full medical evaluation and 1-night PSG at baseline and telephone interview at follow-up.
Results: The rate of incident poor sleep was 18.4%. Physical (e.g., obesity, sleep apnea, and ulcer) and mental (e.g., depression) health conditions 
and behavioral factors (e.g., smoking and alcohol consumption) increased the odds of incident poor sleep as compared to normal sleep. The rates 
of persistent, remitted, and poor sleepers who developed chronic insomnia were 39%, 44%, and 17%, respectively. Risk factors for persistent poor 
sleep were physical health conditions combined with psychologic distress. Shorter objective sleep duration and a family history of sleep problems 
were risk factors for poor sleep evolving into chronic insomnia.
Conclusions: Poor sleep appears to be primarily a symptom of physical and mental health conditions, whereas the persistence of poor sleep is 
associated with psychologic distress. Importantly, sleep apnea appears to be associated with incident poor sleep but not with chronic insomnia. 
Finally, this study suggests that objective short sleep duration in poor sleepers is a biologic marker of genetic predisposition to chronic insomnia.
Keywords: Incidence, persistence, poor sleep, chronic insomnia, polysomnography
Citation: Fernandez-Mendoza J; Vgontzas AN; Bixler EO; Singareddy R; Shaffer ML; Calhoun SL; Karataraki M; Vela-Bueno A; Liao D. Clinical and 
polysomnographic predictors of the natural history of poor sleep in the general population. SLEEP 2012;35(5):689-697.
SLEEP, Vol. 35, No. 5, 2012 690 Natural History of Poor Sleep—Fernandez-Mendoza et al
tion of 4% arterial blood oxygen saturation.14,15 For the purpose 
of this study, the presence of sleep apnea was established on 
3 levels of severity. The absence of sleep apnea was defined 
as an apnea/hypopnea index (AHI) < 5, mild sleep apnea was 
defined as an AHI 5-14.9, and moderate to severe sleep apnea 
was defined as an AHI ≥ 15. Body mass index was based on 
measured height (cm) and weight (kg) during the participants’ 
sleep laboratory visit, and data are presented in terms of mean 
and percentage within each category.
As part of this protocol we also assessed for the presence 
of all sleep disorders, based on a standardized questionnaire 
completed by the participants on the evening of their sleep 
laboratory visit. This questionnaire consists of 53 questions 
(7 demographic, 20 sleep related, and 26 general health ques-
tions). In addition, women responded to 8 questions related to 
menstrual history, menopause, and hormone therapy. Sleep re-
lated questions were qualified in terms of severity on a scale of 
0-3 (0 = none, 1 = mild, 2 = moderate, 3 = severe) and duration. 
Health conditions were also qualified in terms of severity, type 
of treatment (on a scale of 0-7), and duration. The presence of 
sleep difficulty was established on 3 levels of severity. First, 
chronic insomnia was defined as a complaint of insomnia (i.e., a 
positive response to the question “Do you feel you have insom-
nia?”) with a duration of ≥ 1 yr. Second, poor sleep was defined 
as a moderate to severe complaint (based on a mild to severe 
scale) of difficulty falling asleep (“Do you have difficulty fall-
ing asleep?”), difficulty staying asleep (“Do you have difficulty 
staying asleep?”), early final awakening (“Do you wake up in 
the morning earlier than desired?”), or unrefreshing sleep (“Do 
you still feel groggy and unrefreshed after morning awaken-
ing?”). Third, normal sleep was defined as the absence of either 
of these 2 categories. To create 3 mutually exclusive categories, 
none in the poor sleep group reported having chronic insomnia 
and none in the normal sleeping group reported either chronic 
insomnia or poor sleep.
Additional information obtained from the standardized 
questionnaire included assessing physical and mental health, 
substance use, and family history of sleep problems. We as-
certained whether the respondent was currently being treated 
for physical (e.g., hypertension, diabetes, thyroidism) and/or 
mental (e.g., depression, alcohol use, drug use) health condi-
tions. A composite variable for each general category of physi-
cal or mental health conditions was calculated by indicating a 
positive response when at least 1 health condition within each 
category was present, as we have described in other studies.2,9,10 
We also ascertained respondents’ daily consumption of caffeine 
(number of cups/day), tobacco (number of cigarettes/day), and 
alcohol (number of drinks/day). We defined a positive family 
history of sleep problems as a moderate to severe answer (based 
on a mild to severe scale) to the question “Does anyone in your 
family (blood relatives) have sleep problems?” From the 1,741 
individuals, a total of 1,300 completed a valid Minnesota Mul-
tiphasic Personality Inventory-2 (MMPI-2) at baseline. The 
MMPI-2 was administered following the standardized rules and 
scored accordingly.19
Follow-up measures taken through telephone interview in-
cluded the standardized questionnaire that participants com-
pleted at baseline during their sleep laboratory visit. Sleep 
related questions were also used to establish the presence of 
holds in 2 counties of central Pennsylvania (Dauphin and Leba-
non) using the Mitofsky-Waksberg 2-stage random digit dialing 
procedure.16 A within-household selection procedure described 
by Kish17 was used to select the specific man or woman to be 
interviewed. Telephone interviews were conducted with 4,364 
age-eligible men and 12,219 age-eligible women residing in the 
sample households, for a total sample of 16,583 with response 
rates of 73.5% and 74.1%, respectively. The questionnaire used 
in this interview included basic demographic and sleep infor-
mation. In the second phase of this study, a subsample of 741 
men and 1,000 women, selected randomly from those individu-
als previously interviewed by telephone, were studied in our 
sleep laboratory. The response rates for this phase were 67.8% 
and 65.8% for men and women, respectively. After providing 
a complete description of the study to the individuals, written 
informed consent was obtained. We contrasted those individu-
als who were recorded in the laboratory with those who were 
selected but not recorded in terms of age, body mass index, and 
prevalence of sleep disorders. There were no significant differ-
ences between these 2 groups on any of these variables.
Of the 1,741 individuals who completed the comprehensive 
sleep evaluation, 1,395 were followed up after an average du-
ration of 7.5 yr (mean duration of 4.5 yr for women and 10.5 
yr for men) by 1 of the investigators (S.L.C.) via telephone in-
terview. The response rate of the follow-up study was 79.7%. 
However, if one considers that 215 individuals died between 
baseline and follow-up, then the response rate of those alive 
was 90.9%. In the Penn State Cohort Study, men were recruited 
first and women 5 yr later. This explains the 5-yr difference in 
the follow-up period between men and women. After complete 
description of the follow-up study to the individuals, verbal in-
formed consent was obtained. The entire study procedure was 
approved by the University’s Institutional Review Board.
Key Measurements
Each participant selected for laboratory evaluation complet-
ed a comprehensive sleep history and physical examination. 
All participants were evaluated for 1 night in the sleep labo-
ratory in sound-attenuated, light- and temperature-controlled 
rooms. During this evaluation, each participant was continu-
ously monitored for 8 h (fixed-time period) using 16-channel 
PSG including electroencephalogram, electrooculogram, and 
electromyogram. Bedtimes were adjusted to conform to par-
ticipants’ usual bedtimes, and participants were recorded be-
tween 22:00-23:00 and 06:00-07:00. The sleep recordings were 
subsequently scored independently, according to Rechtschaffen 
and Kales criteria.18 The percentage of sleep time is total sleep 
time divided by recorded time in bed and multiplied by 100. 
Additional information obtained during the PSG included that 
assessing sleep apnea. Respiration was monitored throughout 
the night by use of thermocouples at the nose and mouth and 
thoracic strain gauges. All-night recordings of hemoglobin oxy-
gen saturation (SpO2) were obtained with an oximeter attached 
to the finger. Apnea was considered present if a breath cessa-
tion exceeded 10 sec and each apnea was categorized in terms 
of obstructive (chest wall movement present) or central (chest 
wall movement absent). In addition, hypopnea was considered 
present when a reduction in air flow of approximately 50% was 
indicated at the nose or mouth and was associated with a reduc-
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tion, as well as stratified according to poor sleep status. The 
normal sleep group was used as the reference for incident 
poor sleep, whereas the remitted poor sleep group was used 
as the reference for persistent poor sleep. Analysis of variance 
(ANOVA) was used to examine mean differences on quanti-
tative variables between the study groups. Chi-square tests 
were used to examine differences between the study groups on 
qualitative variables. Multivariable logistic regression models 
were used to assess the independent association of each risk 
factor with incident or persistent poor sleep. We calculated the 
odds ratios (OR) and the 95% confidence intervals (95% CIs) 
from the regression models to estimate the risk of incident or 
persistent poor sleep associated with each risk factor, simulta-
neously adjusting for covariates. Multivariate analysis of co-
variance (MANCOVA) was used to examine mean differences 
on MMPI-2 scores between the study groups, while controlling 
for potential confounding factors. Bonferroni corrections were 
applied to control for type I errors when performing post hoc 
multiple comparisons. All analyses were conducted with SPSS 
version 17.0 for Windows.
RESULTS
The rate of incident poor sleep was 18.4%. The rates of per-
sistent poor sleepers, remitted poor sleepers, and poor sleepers 
sleep difficulty at follow-up based 
on 3 levels of severity as defined 
previously (i.e., normal sleep, poor 
sleep, and chronic insomnia).
Sample
Of the 1,395 participants who 
were followed up, 149 had chronic 
insomnia, 403 had poor sleep, and 
843 had normal sleep at baseline. 
Because the focus of the current 
study is the natural history of 
poor sleep, those individuals with 
chronic insomnia at baseline were 
excluded from further analysis; 
these individuals were part of a 
study on risk factors for persistent 
chronic insomnia.20 All partici-
pants selected for the current study 
were further classified according 
to their baseline and follow-up 
status into 4 groups: normal sleep 
(individuals with normal sleep 
both at baseline and at follow-
up; n = 590), incident poor sleep 
(individuals with normal sleep 
at baseline and with poor sleep 
at follow-up; n = 188), persis-
tent poor sleep (individuals with 
poor sleep both at baseline and at 
follow-up; n = 155), and remitted 
poor sleep (individuals with poor 
sleep at baseline and with normal 
sleep at follow-up; n = 180). Two 
additional groups were obtained 
for secondary analysis of the natural history of poor sleep: poor 
sleepers who developed chronic insomnia (individuals with 
poor sleep at baseline and with chronic insomnia at follow-up; 
n = 68) and normal sleepers who developed chronic insomnia 
(individuals with normal sleep at baseline and with chronic in-
somnia at follow-up; n = 65). Figure 1 shows the participant 
flow in the study.
Statistical Analyses
The design of this study included oversampling of those 
at higher risk for sleep disordered breathing and women with 
markedly higher levels of body mass index to increase the pre-
cision of the risk estimates. Because of this sampling strategy, 
numeric sampling weights were developed for the analysis so 
that the estimates could be inferred to the general population. A 
comprehensive presentation of this sampling strategy has been 
described,2,6-11,14,15 including the use of the NHANES III labora-
tory data as the standard to adjust both the men and women in 
terms of sociodemographics to be representative of the national 
population. Therefore, we adjusted for the sampling weight in 
all of our analyses, including those estimating incidence and 
persistence rates.
Mean (standard deviation, SD) and proportions of the demo-
graphic characteristics were calculated for the entire popula-
Figure 1—Participants’ flow in the study.
Phase I: Telephone Survey 
(N = 16,583)
Phase II: Sleep Lab Study 
Baseline (N = 1,741)
Follow-Up Survey (N = 1,395)
• Mean duration 7.5 years
• 215 cases deceased
• 131 cases could not be reached
Normal Sleep at Follow-up
Normal Sleep
(n = 590)
Poor Sleep at Follow-up
Incident Poor Sleep
(n = 188)
Chronic Insomnia at Follow-up
Incident Chronic Insomnia
(n = 65)
Normal Sleep at Follow-up
Remitted Poor Sleep
(n = 180)
Poor Sleep at Follow-up
Persistent Poor Sleep
(n = 155)
Chronic Insomnia at Follow-up
Incident Chronic Insomnia
(n = 68)
Poor Sleep at Baseline 
Included (n = 403)
Normal Sleep at Baseline
Included (n = 843)
Chronic Insomnia at Baseline
Excluded (n = 149)
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3.45; P < 0.001) and mental health conditions (OR = 2.19; 95% 
CI = 1.38-3.47; P = 0.001) was of similar magnitude. Smoking 
(OR = 1.02; 95% CI = 1.01-1.03; P = 0.031) was also a signifi-
cant predictor of incident poor sleep in this secondary model.
Persistent Poor Sleep
Persistent poor sleep was significantly associated with middle 
age (P = 0.003), heart disorder (P = 0.002), ulcer (P = 0.012), 
and allergy/asthma (P = 0.040), and marginally associated with 
depression (P = 0.056), smoking (P = 0.059), and male sex 
(P = 0.099), when compared with remitted poor sleep. Fur-
thermore, the group of participants with persistent poor sleep 
showed significantly higher scores in the 1-Hypochondriasis, 
2-Depression, and 7-Psychasthenia clinical scales of the MMPI-
2, when compared with remitted poor sleepers (Table 4).
In a multivariable logistic regression model, the risk fac-
tors that significantly increased the odds of persistent poor 
sleep were: heart disorder (OR = 3.43; 95% CI = 1.41-8.33; 
P = 0.007), ulcer (OR = 2.62; 95% CI = 1.07-6.45; P = 0.036), 
middle age (OR = 2.19; 95% CI = 1.11-4.33; P = 0.024), and 
allergy/asthma (OR = 1.99; 95% CI = 1.05-3.76; P = 0.035).
Development of Chronic Insomnia
As shown in Table 5, the risk factors associated with the de-
velopment of chronic insomnia from poor sleep, as compared 
with normal sleep, in a multivariable logistic regression model 
were female sex, age younger than 40 yr, depression, smoking, 
fewer physical health conditions, and shorter objective sleep 
duration. Furthermore, a higher percentage of poor sleepers, 
who developed chronic insomnia were 39%, 44%, and 17%, 
respectively. The demographic, clinical, and behavioral charac-
teristics of the study sample and stratified by poor sleep status 
are presented in Table 1.
Incident Poor Sleep
Individuals with incident poor sleep were significantly more 
obese (P = 0.020), smoked more cigarettes (P = 0.015), and 
consumed more alcohol (P = 0.040) at baseline when compared 
with normal sleepers (Table 1). Having ulcer (P = 0.0001) and 
depression (P = 0.002) at baseline were significantly associat-
ed with incident poor sleep when compared with normal sleep 
(Table 2). Moderate to severe sleep apnea (AHI ≥ 15) at baseline 
was significantly associated with incident poor sleep (P = 0.039; 
Table 3). Moreover, the group with incident poor sleep showed 
significantly higher scores in all MMPI-2 scales, except 3-Hys-
teria, when compared with normal sleepers (Table 4).
A multivariable logistic regression model showed that ul-
cer (OR = 7.00; 95% CI = 3.31-14.8; P = 0.0001), depression 
(OR = 2.04; 95% CI = 1.17-3.57; P = 0.012), obesity (OR = 1.70; 
95% CI = 1.13-2.55; P = 0.010), and smoking (OR = 1.02; 95% 
CI = 1.01-1.03; P = 0.024) significantly increased the odds of 
incident poor sleep compared with normal sleep, whereas sleep 
apnea (AHI ≥ 15) was only marginally associated with inci-
dent poor sleep (OR = 1.83; 95% CI = 0.94-3.54; P = 0.074) 
and alcohol consumption (OR = 1.01; 95% CI = 0.99-1.04; 
P = 0.159) did not remain as a significant predictor. The risk of 
incident poor sleep associated with physical health conditions, 
i.e., ulcer, obesity, and AHI ≥ 15 (OR = 2.32; 95% CI = 1.56-
Table 1—Sociodemographic and behavioral characteristics at baseline
Normal sleep
(n = 590)
Incident poor sleep
(n = 188)
Remitted poor sleep
(n = 180)
Persistent poor sleep
(n = 155)
Female, % 44.9 41.3 57.1 46.4
Caucasian, % 93.3 93.0 96.1 96.4
Age, yr 49.9 (13.2) 50.1 (12.2) 46.1 (13.5) 48.8 (12.2)
20-40, % 25.0 22.2 42.1 21.4
40-60, % 50.8 54.1 40.5 58.0
≥ 60, % 24.2 23.8 17.5 20.5
Body mass index, kg/m2 26.8 (4.3) 27.7 (5.2) 29.2 (5.5) 29.2 (6.0)
Obesity, % 18.4 26.1 35.7 34.2
Caffeine, cups/day 2.2 (2.5) 2.4 (3.5) 2.3 (2.5) 2.8 (3.7)
None, % 33.7 38.9 27.8 24.1
1-2 cups/day, % 33.3 24.3 33.3 43.8
≥ 3 cups/day, % 33.0 36.8 38.9 32.1
Tobacco, cigarettes/day 3.6 (9.2) 5.8 (16.0) 3.5 (7.9) 5.5 (12.2)
None, % 78.9 80.4 75.2 77.0
1-20 cigarettes/day, % 10.5 6.0 14.4 6.2
≥ 20 cigarettes/day, % 10.6 13.6 10.4 16.8
Alcohol, drinks/day 1.2 (6.9) 2.4 (7.6) 1.0 (2.7) 0.9 (2.6)
None, % 72.0 63.4 74.0 77.7
1 drink/day, % 12.2 14.2 7.9 5.4
≥ 2 drinks/day, % 15.7 22.4 18.1 17.0
Family history of sleep problems, % 5.7 6.5 15.9 11.0
All data are adjusted for sampling weight. Where appropriate the standard deviation is presented in parentheses (SD). Obesity was defined as a body mass 
index ≥ 30.
SLEEP, Vol. 35, No. 5, 2012 693 Natural History of Poor Sleep—Fernandez-Mendoza et al
shown; e.g., mean number of MMPI-2 elevations, 2.0 ± 2.2 
versus 0.8 ± 2.1).
DISCUSSION
The main findings of this population-based, longitudinal 
study are that incident poor sleep is associated with both physi-
as compared with normal sleepers who developed chronic in-
somnia, had a family history of sleep problems (35% versus 
3%, respectively; P < 0.0001). Finally, poor sleepers who de-
veloped chronic insomnia showed higher scores in all MMPI-2 
clinical scales except 9-Hypomania when compared with nor-
mal sleepers who also developed chronic insomnia (data not 
Table 2—Physical and mental health conditions at baseline
Normal sleep
(n = 590)
Incident poor sleep
(n = 188)
Remitted poor sleep
(n = 180)
Persistent poor sleep
(n = 155)
Physical health conditions, % 55.8 69.0 73.8 78.4
Allergy/asthma 23.1 27.7 21.3 33.0
Anemia 6.3 8.2 13.4 7.1
Colitis 1.9 1.6 4.8 3.6
Diabetes 5.4 3.8 6.3 5.4
Epilepsy 1.3 1.1 1.6 0.0
Heart disorder 6.9 9.8 7.1 20.5
Hypertension 15.0 19.6 23.8 19.6
Kidney/bladder 7.3 4.9 7.9 11.7
Migraine 8.5 10.3 18.3 18.8
Rheumatism 6.2 7.1 8.7 6.3
Stroke 1.6 1.1 2.4 1.8
Thyroid 3.5 2.7 8.7 4.5
Ulcer 1.7 9.8 7.1 17.9
Mental health conditions, % 9.4 19.0 31.7 40.2
Depression 6.3 13.0 25.2 36.6
Alcohol use disorder 0.9 0.5 1.6 3.6
All data are adjusted for sampling weight.
Table 3—Polysomnographic characteristics at baseline
Normal sleep
(n = 590)
Incident poor sleep
(n = 188)
Remitted poor sleep
(n = 180)
Persistent poor sleep
(n = 155)
SOL, min 32.0 (1.2) 31.4 (2.4) 33.4 (3.1) 33.6 (3.1)
WASO, min 90.7 (1.9) 91.5 (3.7) 94.4 (4.8) 94.6 (4.9)
Total sleep time, min 352.3 (2.5) 352.7 (5.0) 349.8 (6.5) 347.5 (6.6)
Total wake time, min 122.7 (2.5) 122.9 (4.9) 127.8 (6.3) 128.3 (6.5)
Number of awakenings, n 11.4 (0.2) 11.7 (0.4) 12.0 (0.5) 12.4 (0.6)
Sleep efficiency, % 74.2 (0.5) 74.2 (1.0) 73.2 (1.3) 72.9 (1.4)
Stage 1, % 12.1 (0.3) 10.6 (0.6) 11.7 (0.7) 10.9 (0.7)
Stage 2, % 68.3 (0.3) 69.3 (0.7) 68.3 (0.9) 68.7 (0.9)
Stage 3, % 2.7 (0.2) 2.4 (0.3) 3.1 (0.4) 2.9 (0.4)
Stage 4, % 0.2 (0.1) 0.2 (0.1) 0.8 (0.1) 0.2 (0.1)
SWS (3 + 4), % 2.9 (0.2) 2.6 (0.3) 3.9 (0.4) 3.1 (0.5)
Stage REM, % 16.7 (0.3) 17.5 (0.5) 16.1 (0.6) 17.2 (0.7)
Minimum SaO2 92.8 (0.2) 92.7 (0.4) 92.6 (0.5) 92.2 (0.6)
Obstructive events, n 4.9 (0.8) 7.1 (1.7) 7.1 (2.1) 3.1 (2.2)
Central apnea events, n 1.3 (0.5) 2.9 (1.0) 0.8 (1.3) 0.3 (1.4)
Hypopnea events, n 8.1 (1.0) 8.8 (2.1) 11.5 (2.7) 5.4 (2.7)
Apnea/hypopnea index, % 2.6 (0.3) 3.5 (0.5) 3.5 (0.7) 1.5 (0.7)
< 5 87.5 84.2 85.7 87.5
≥ 5 7.4 6.5 5.6 8.9
≥ 15 5.1 9.2 8.7 3.6
All data are adjusted for sex, age, body mass index, race, physical and mental health conditions, and sampling weight. Where appropriate the standard error 
of the mean is presented in parenthesis. SOL, sleep onset latency; SWS, slow wave sleep; WASO, wake time after sleep onset.
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into chronic insomnia, which is usually associated with pro-
longed periods of wake at the beginning or in the middle of 
the sleep period. This hypothesis is based on the fact that sleep 
loss in the form of sleep deprivation or sleep fragmentation in 
individuals without insomnia is associated with physiologic 
sleepiness, i.e., shortened sleep latencies in the multiple sleep 
latency test (MSLT),38 whereas in chronic insomnia sleep dis-
ruption, i.e., prolonged sleep latency and/or awakenings, is 
not associated with physiologic sleepiness, as revealed by in-
creased sleep latencies in the MSLT.39 Thus, these findings are 
consistent with a model of chronic insomnia being a disorder 
of physiologic hyperarousal.40-43
The rate of persistent poor sleep in the current study was 39%, 
which is similar to that reported by Morin and colleagues,13 who 
followed individuals with insomnia symptoms for 3 yr. Other 
studies have reported persistence rates that ranged from 44-
69%; however, they were limited by either focusing on elderly 
populations, men, or having a shorter follow-up period.21,44,45 
Furthermore, our study showed for the first time that middle age 
and physical health (e.g., heart disorder, ulcer, and allergy/asth-
ma), when associated with psychologic distress, are the primary 
risk factors of the persistence of poor sleep. This is supported 
by the fact that remitted poor sleepers did not show significant 
overall psychologic distress as compared with normal sleepers.
In approximately 17% of individuals, poor sleep evolved 
into chronic insomnia. This means that approximately 4% of 
the general population that perceive themselves as poor sleep-
ers will develop chronic insomnia. Given that chronic insom-
nia is associated with significant morbidity6,8-10 and mortality,11 
identifying risk factors associated with this outcome is crucial 
to developing preventive strategies. In our study, young age, 
female sex, mental health conditions (including maladaptive 
personality traits), objective short sleep duration, and a family 
history of sleep problems were significant risk factors for poor 
sleep evolving into chronic insomnia. Focusing on these demo-
graphic groups (i.e., young women) or addressing modifiable 
cal and mental health conditions, psychologic distress is the 
link between physical problems and the persistence of poor 
sleep, and objective short sleep duration in poor sleepers is a 
biologic marker of predisposition to chronic insomnia.
Limited information exists on the risk factors associated 
with incident poor sleep. A previous general population study 
showed that the incidence of insomnia symptoms was associ-
ated primarily with baseline self-reported anxiety, depression, 
and pain.21 In the current study the incidence of poor sleep, i.e., 
moderate-to-severe insomnia symptoms, was associated with 
both physical (e.g., ulcer, obesity, and sleep apnea) and mental 
health conditions (e.g., depression and maladaptive personal-
ity traits) as well as behavioral (e.g., smoking and alcohol con-
sumption) factors. An interesting finding of our study is that 
obesity was an independent risk factor for incident poor sleep. 
In addition, individuals in whom chronic insomnia developed, 
either from a premorbid status of normal sleep or poor sleep, 
were also significantly more obese at baseline when compared 
with normal sleepers. Taken together, our results suggest that 
metabolic aberrations associated with obesity may play a role in 
the development of poor sleep and chronic insomnia.
Another important finding of our study is that moderate to 
severe sleep apnea (AHI ≥ 15) is a risk factor of incident poor 
sleep. Since the 1970s, there have been reports suggesting that 
sleep apnea is associated with chronic insomnia,22-30 whereas 
other large studies have not shown a significant association 
between sleep apnea and chronic insomnia.2,31-37 Our findings 
based on a general population longitudinal study appear to 
shed new light on this old controversy. Whereas in our previ-
ous cross-sectional and longitudinal studies there was a lack 
of association between sleep apnea with prevalent,2 incident,7 
or persistent20 chronic insomnia, poor sleep, i.e., insomnia 
symptoms, can indeed be a consequence of sleep apnea. Thus, 
it appears that sleep apnea through breathing pauses and in-
termittent hypoxia can lead to sleep disruption, i.e., frequent 
brief awakenings, but this sleep disruption does not evolve 
Table 4—MMPI-2 scores at baseline
Normal sleep
(n = 464)
Incident poor sleep
(n = 154)
Remitted poor sleep
(n = 142)
Persistent poor sleep
(n = 117)
Number of elevations 0.5 (0.1) 1.3 (0.1)a 0.5 (0.1) 1.4 (0.1)b,d
1-Hypochondriasis 53.4 (0.4) 56.8 (0.8)a 54.0 (1.0) 58.2 (1.1)b,d
2-Depression 48.0 (0.4) 54.2 (0.9)a 49.6 (1.1) 54.4 (1.2)b,d
3-Hysteria 52.7 (0.4) 54.5 (0.8) 52.1 (1.1) 55.6 (1.1)
4-Psychopathic deviate 49.7 (0.4) 53.2 (0.8)a 53.2 (1.1)c 54.2 (1.1)b
6-Paranoia 49.5 (0.4) 52.5 (0.8)a 48.5 (1.1) 51.7 (1.2)
7-Psychasthenia 48.5 (0.4) 53.1 (0.8)a 47.8 (1.1) 54.3 (1.1)b,d
8-Schizophrenia 47.3 (0.4) 49.9 (0.8)a 48.1 (1.0) 49.5 (1.1)
9-Hypomania 47.1 (0.4) 50.2 (0.8)a 48.8 (1.0) 47.9 (1.1)
0-Social introversion 47.5 (0.4) 51.7 (0.8)a 50.1 (1.0) 52.5 (1.1)b
 Depression 44.9 (0.4) 49.6 (0.8)a 49.5 (1.0)c 51.2 (1.1)b
 Anxiety 47.9 (0.4) 51.0 (0.8)a 49.6 (1.0) 50.3 (1.1)
 Ego strength 50.0 (0.4) 46.3 (0.8)a 47.7 (1.0) 47.0 (1.1)b
All values are mean (standard error of the mean) adjusted for age, sex, and mental health conditions. aP < 0.05, normal sleep versus incident poor sleep; 
bP < 0.05, normal sleep versus persistent poor sleep; cP < 0.05, remitted poor sleep versus normal sleep; dP < 0.05, remitted poor sleep versus persistent 
poor sleep.
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The issue of whether insomnia is a disorder or a symptom 
of an underlying physical or mental health condition has long 
been debated but no definite conclusions have been reached. 
We have previously proposed that chronic insomnia with ob-
jective short sleep duration is a disorder associated with physi-
ologic hyperarousal and significant morbidity and mortality. In 
contrast, chronic insomnia with objective normal sleep duration 
is not associated with physiologic hyperarousal or significant 
medical sequelae. This study shows that poor sleep is primarily 
a symptom of underlying physical or mental health conditions, 
whereas poor sleep with objective short sleep duration is in a 
continuum with chronic insomnia.
Some limitations should be taken into account when inter-
preting our results. The objective sleep in this study was based 
on 1 night of PSG, which may not be representative of the par-
ticipants’ typical or optimal objective sleep duration and may 
be affected by the so-called first night effect. In large epidemio-
factors (i.e., mental health and smoking) will be associated with 
higher success of preventive strategies.
A novel finding of our study is that objective short sleep 
duration is a risk factor predisposing to chronic insomnia. We 
have previously postulated that objective short sleep dura-
tion is an index of the biologic severity of chronic insom-
nia6,8-11,40,41 and a predictor of its persistence over time.20 This 
study suggests that objective short sleep duration is also a 
marker of predisposition to this disorder, i.e., who among 
poor sleepers will develop chronic insomnia. We believe 
that, in chronic insomnia, objective short sleep duration is 
a marker of physiologic hyperarousal40-42 determined by bio-
logic/genetic factors. In this regard, the strong family history 
of moderate to severe sleep complaints in poor sleepers who 
developed chronic insomnia (35%) compared with normal 
sleepers (3%) who also developed chronic insomnia lends 
support to this hypothesis.
Table 5—Development of chronic insomnia from poor sleep versus normal sleep at baseline
Normal sleepers who 
developed insomnia
(n = 65)
Poor sleepers who 
developed insomnia
(n = 68)
Multivariable logistic regressiona
OR (95% CI) P
Female, % 51.4 86.0 5.08 (1.58-16.3) 0.006*
Caucasian, % 85.7 92.0 0.98 (0.21-4.54) 0.978
Age, yr 45.5 (14.5) 45.4 (12.2) — — —
 20-40, % 32.9 49.0 3.85 (1.14-12.9) 0.029*
 40-60, % 52.9 34.7 0.46 (0.12-1.75) 0.255
 ≥ 60, % 14.3 16.3 1.0 — —
Body mass index, kg/m2 27.3 (7.4) 28.7 (6.3) — — —
 Obesity, % 30.0 34.0 1.86 (0.58-5.90) 0.294
Caffeine, cup/day 2.9 (3.1) 3.4 (4.4) 0.95 (0.82-1.11) 0.553
 None, % 30.0 32.0 — — —
 1-2 cups/day, % 20.0 22.0 — — —
 ≥ 3 cups/day, % 50.0 46.0 — — —
Tobacco, cigarettes/day 1.9 (6.7) 4.2 (8.8) 1.06 (1.01-1.13) 0.044*
 None, % 83.1 77.6 — — —
 1-20 cig/day, % 14.1 6.1 — — —
 ≥ 20 cig/day, % 2.8 16.3 — — —
Alcohol, drink/day 1.1 (2.9) 0.2 (0.8) 0.74 (0.45-1.21) 0.226
 None, % 76.1 91.8 — — —
 1 drink/day, % 9.9 0.0 — — —
 ≥ 2 drinks/day, % 14.1 8.2 — — —
Physical health conditions, % 74.3 58.0 0.24 (0.08-0.72) 0.011*
Mental health conditions, % 24.3 32.0 — — —
 Depression, % 17.1 28.6 3.85 (1.93-15.9) 0.063
Polysomnography
 SOL, min 32.8 (25.0) 28.8 (32.2) 0.99 (0.98-1.01) 0.516
 WASO, min 73.6 (50.0) 100.0 (63.5) 1.02 (1.01-1.03) 0.012*
 Total sleep time, min 371.7 (59.0) 345.6 (75.0) 0.98 (0.97-0.99) 0.034*
 Apnea/hypopnea index, % 2.9 (7.2) 1.7 (9.1) 0.99 (0.94-1.04) 0.621
 < 5 90.0 90.0 — — —
 ≥ 5 2.9 6.0 — — —
 ≥ 15 7.1 4.0 — — —
All data are adjusted for sampling weight. aPolysomnographic variables were entered in separate models, except apnea/hypopnea index, which was controlled 
for in all models; the odds ratio (OR) and 95% confidence interval (CI) reported for sociodemographic variables, caffeine, tobacco, alcohol, physical health 
conditions, and depression are those from the model in which total sleep time was entered as a predictor. Where appropriate the standard deviation (SD) is 
presented in parentheses. Obesity, body mass index ≥ 30; SOL, sleep onset latency; WASO, wakefulness after sleep onset. *P < 0.05.
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logic studies the average objective sleep duration is approxi-
mately 6 hr, which is independent of whether sleep is recorded 
at home with PSG (Sleep Heart Health Study)46 or for 3 consec-
utive nights with actigraphy (CARDIA Study)47 or in the sleep 
laboratory with PSG (Penn State Cohort Study).6-11 Thus, the 
consistency among these 3 large epidemiologic studies in terms 
of objective sleep duration supports the validity of our findings. 
In the current study, we did not assess daytime consequences 
of insomnia; however, 3 lines of evidence support the validity 
of our definitions of poor sleep and chronic insomnia. First, all 
of those that identified themselves as having chronic insomnia 
reported 1 or more of the 4 nighttime symptoms used in the 
diagnosis of insomnia, i.e., difficulty falling asleep, difficulty 
staying asleep, early morning awakening, or unrefreshing sleep. 
Second, the prevalence estimates in the Penn State Cohort using 
these definitions2 are similar to those of other population-based 
studies where insomnia symptoms and chronic insomnia/in-
somnia syndrome are defined as 2 mutually exclusive groups.3 
Third, in our previous studies, chronic insomnia was strongly 
associated with cardiometabolic morbidity6,8 and mortality,11 
whereas the association of poor sleep was much smaller or non-
significant. These findings give further support to the face, con-
struct, and predictive validity of the definitions used. Another 
potential limitation is that we have only 1 follow-up time point 
that precludes a more accurate assessment of the waxing and 
waning typical of poor sleep and chronic insomnia over time.13 
Finally, effort-related breathing arousals were not quantified 
during the sleep study,14,15 which did not allow examination of 
their relative contribution in the natural history of poor sleep.
In summary, our data suggest that poor sleep is primarily 
a symptom of diverse physical and mental health conditions, 
whereas the persistence of poor sleep is associated with psycho-
logic distress. Furthermore, objective short sleep duration and 
a family history of sleep problems are predisposing factors for 
poor sleep evolving into chronic insomnia. Finally, poor sleep 
and chronic insomnia with normal sleep duration appear to be in 
a continuum with strong psychologic roots, whereas poor sleep 
and chronic insomnia with objective short sleep duration ap-
pear to be in a continuum with a strong biological background 
(e.g., genetics and physiologic hyperarousal).
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